HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Aurora kinase B/C inhibition impairs malignant glioma growth in vivo.

Abstract
Inhibition of Aurora kinase B has been evaluated as a therapy to block solid tumor growth in breast cancer, hepatocellular carcinoma, lung adenocarcinoma, and colorectal cancer models. Aurora kinase inhibitors are in early clinical trials for the treatment of leukemia. We hypothesized that Aurora B inhibition would reduce malignant glioma cell viability and result in impaired tumor growth in vivo. Aurora B expression is greater in cultured malignant glioma U251 cells compared to proliferating normal human astrocytes, and expression is maintained in U251 flank xenografts. Aurora B inhibition with AZD1152-HQPA blocked cell division in four different p53-mutant glioma cell lines (U251, T98G, U373, and U118). AZD1152-HQPA also inhibited Aurora C activation loop threonine autophosphorylation at the effective antiproliferative concentrations in vitro. Reduction in cell viability of U251 (p53(R273H)) cells was secondary to cytokinesis blockade and apoptosis induction following endoreplication. AZD1152-HQPA inhibited the growth of U251 tumor xenografts and resulted in an increase in tumor cell apoptosis both in vitro and in vivo. Subcutaneous administration of AZD1152-HQPA (25 mg/kg/day × 4 days; 2 cycles spaced 7 days apart) resulted in a prolongation in median survival after intracranial inoculation of U251 cells in mice (P = 0.025). This is the first demonstration that an Aurora kinase inhibitor can inhibit malignant glioma growth in vivo at drug doses that are clinically relevant.
AuthorsRoberto Jose Diaz, Brian Golbourn, Maryam Shekarforoush, Christian A Smith, James T Rutka
JournalJournal of neuro-oncology (J Neurooncol) Vol. 108 Issue 3 Pg. 349-60 (Jul 2012) ISSN: 1573-7373 [Electronic] United States
PMID22382783 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Forkhead Transcription Factors
  • Quinazolines
  • RNA, Messenger
  • Whn protein
  • AZD 1152-HQPA
  • AURKB protein, human
  • AURKC protein, human
  • Aurkb protein, mouse
  • Aurkc protein, mouse
  • Aurora Kinase B
  • Aurora Kinase C
  • Aurora Kinases
  • Protein Serine-Threonine Kinases
Topics
  • Animals
  • Apoptosis (drug effects)
  • Astrocytes (cytology, drug effects, enzymology)
  • Aurora Kinase B
  • Aurora Kinase C
  • Aurora Kinases
  • Blotting, Western
  • Cell Proliferation (drug effects)
  • Cells, Cultured
  • Fluorescent Antibody Technique
  • Forkhead Transcription Factors (physiology)
  • Glioma (enzymology, pathology, prevention & control)
  • Humans
  • Immunoenzyme Techniques
  • Male
  • Mice
  • Mice, Nude
  • Protein Serine-Threonine Kinases (antagonists & inhibitors, metabolism)
  • Quinazolines (therapeutic use)
  • RNA, Messenger (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: